Procainamide and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Procainamide
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and addiction medicine) and procainamide (a heart rhythm medicine) can each affect the electrical timing of your heartbeat, something doctors call the QT interval. When you take them together, that effect can add up, which in rare cases could lead to an irregular heartbeat.
I want to be honest with you: this concern is mostly theoretical, meaning it is based on how the drugs work rather than lots of real-world reports. Please don't stop either medicine on your own. Your care team can manage this well, often by keeping an eye on your heart and your blood minerals. Just make sure both your doctor and pharmacist know you take these together.
Effect: Additive risk of QT interval prolongation with concurrent buprenorphine and procainamide.
Mechanism: Pharmacodynamic (additive) QT prolongation. Neither agent is a relevant prodrug here; the interaction is PD, not PK-driven. Procainamide is a Class Ia antiarrhythmic with intrinsic QT/QRS effects; buprenorphine carries a dose-related QT signal.
Evidence: Theoretical; magnitude and onset unspecified. Severity rated major.
- Assess baseline and periodic ECG (QTc) if co-use is unavoidable.
- Correct and monitor K+ and Mg2+; screen for bradycardia, HF, congenital long-QT.
- Avoid other QT-prolonging agents; individualize therapy.
Manufacturer guidance favors avoiding the combination when feasible.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Concurrent administration of buprenorphine with medications capable of prolonging the QT interval should be avoided342. It remains unknown what risk arises from pairing buprenorphine with additional QT-prolonging agents. When prescribing buprenorphine to patients who have risk factors including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, clinicians should take these considerations into account in their decision-making1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
The main concern is that both drugs can stretch the heart's QT interval, and the effect may add up. Here is how a care team typically handles this:
- They may avoid the combination when another option is available, or use it with extra caution.
- They may monitor you more closely, including checking your heart rhythm (ECG) and blood levels of potassium and magnesium.
- They pay special attention if you have a slow heart rate, heart failure, or a known long-QT condition.
What you should do: Keep taking both exactly as prescribed unless told otherwise. Tell your pharmacist or prescriber that you take these together, and report symptoms like fainting, dizziness, or a fluttering heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Procainamide and Buprenorphine together?
Buprenorphine and procainamide can each prolong the QT interval, and combining them may add to that risk, so let your care team decide whether to avoid the pair or monitor your heart and electrolytes closely. Don't stop either drug on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Procainamide and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Procainamide and Buprenorphine interaction managed?
The main concern is that both drugs can stretch the heart's QT interval, and the effect may add up. Here is how a care team typically handles this: They may avoid the combination when another option is available, or use it with extra caution. They may monitor you more closely, including checking your heart rhythm (ECG) and blood levels of potassium and magnesium. They pay special attention if you… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Procainamide or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Procainamide
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist